Author name: Ashley Owen

by Howard Hall, SVP Enterprise Growth, Maxor The purpose of the 340B Drug Pricing Program continues to spark debate, particularly […]

Equity in healthcare series – part 7 May marks Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Heritage Month—a time

Equity in healthcare series – part 6 Clinical trials are essential to advancing medical knowledge and improving patient outcomes. According

Drug shortages remain a significant issue in the United States in 2025. As of April 17, there are 270 active

Equity in healthcare series – part 5 The words we use matter—especially in healthcare. Language shapes perceptions, influences behavior, and

Autoimmune diseases occur when the immune system—which normally defends the body against illness—mistakenly attacks healthy cells, tissues, or organs. This

As the 340B program faces unprecedented pressure from legislators, manufacturers, and courts, health system leaders must prepare for a new

When we hear the word “rare,” we might think of something uncommon or unlikely to happen. But in the world

Equity in healthcare series – part 4 Introduction Autoimmune diseases occur when the immune system malfunctions and mistakenly attacks the

Introduction In the U.S., drugs have three types of names: chemical, generic, and brand. Here’s how each is determined. Chemical